Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Almotriptan
Drug ID BADD_D00077
Description Almotriptan is a triptan drug for the treatment of migraine headaches. Almotriptan is in a class of medications called selective serotonin receptor agonists. It works by narrowing blood vessels in the brain, stopping pain signals from being sent to the brain, and stopping the release of certain natural substances that cause pain, nausea, and other symptoms of migraine. Almotriptan does not prevent migraine attacks.
Indications and Usage For the treatment of acute migraine headache in adults
Marketing Status Prescription
ATC Code N02CC05
DrugBank ID DB00918
KEGG ID D02824
MeSH ID C409045
PubChem ID 123606
TTD Drug ID D0P0SM
NDC Product Code 27241-041; 0378-5245; 27241-042; 0378-5246
Synonyms almotriptan | almotriptan malate | Axert | Almogran
Chemical Information
Molecular Formula C17H25N3O2S
CAS Registry Number 154323-57-6
SMILES CN(C)CCC1=CNC2=C1C=C(C=C2)CS(=O)(=O)N3CCCC3
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Hemiplegia17.01.04.002--Not Available
Hyperacusis17.04.03.003; 04.02.02.001--Not Available
Hypercholesterolaemia14.08.01.001--Not Available
Hyperglycaemia05.06.02.002; 14.06.02.002--
Hyperhidrosis08.01.03.028; 23.02.03.004--
Hyperreflexia17.02.01.002--Not Available
Hypersensitivity10.01.03.003--
Hypertension24.08.02.001--
Hypertonia17.05.02.001; 15.05.04.007--Not Available
Hyperventilation22.02.01.006; 19.01.02.004--Not Available
Hypoaesthesia17.02.06.023--Not Available
Immune system disorder10.02.01.001--Not Available
Insomnia19.02.01.002; 17.15.03.002--
Laryngitis22.07.03.001; 11.01.13.001--
Laryngospasm22.04.02.002--
Loss of consciousness17.02.04.004--Not Available
Malaise08.01.01.003--
Mental disability26.01.01.001--Not Available
Mental impairment19.21.02.003; 17.03.03.002--Not Available
Muscular weakness17.05.03.005; 15.05.06.001--
Myalgia15.05.02.001--
Myocardial infarction02.02.02.007; 24.04.04.009--
Myocardial ischaemia24.04.04.010; 02.02.02.008--Not Available
Myopathy15.05.05.001--Not Available
Nausea07.01.07.001--
Neck pain15.03.04.009--
Nervous system disorder17.02.10.001--Not Available
Nervousness19.06.02.003--Not Available
Neuropathy peripheral17.09.03.003--Not Available
Nightmare19.02.03.003--Not Available
The 3th Page    First    Pre   3 4 5    Next   Last    Total 5 Pages